Second-line treatment of gastric cancer or cancer of the gastrointestinal junction: a case study of ramucirumab in Hong Kong
In Hong Kong, gastric cancer is the sixth most incident cancer and the sixth highest mortality cancer, with 1,314 cases and 682 deaths reported in 2017. Dr Wendy Chan, Clinical Assistant Professor at the University of Hong Kong, discusses the latest developments in the treatment of gastric and GEJ cancers.
ASCO 2019 Lung Cancer: 36 Oral Presentations of the ASCO19 lung cancer track summarised
Non-small cell lung cancer (NSCLC) was a key feature of the American Society of Clinical Oncology (ASCO) 2019 annual meeting. This year, exciting results with neoadjuvant immunotherapy (I-O) from the LCMC3, NEOSTAR, and GECP16/03_NADIM studies as well as combinations of I-O and PARP-inhibitors with chemoradiation therapy, and more. A summary of 36 oral presentations on NSCLC, SCLC, and Mesothelioma.
Updated: Clinical characteristics of patients with COVID-19
Dr Siddharth analysed the clinical characteristics of 1,689 #COVID19 patients from 21 publications, and the demographics of 2,198 2019nCoV patients.
CANCERINFORMER
BREAKING
